Ingen internetforbindelse — viser den gemte version af siden.

Greenland Mines L…

USUSD
← Til Screeneren

Greenland Mines Ltd (US:GRML) — Biotechnology: Biological Products (No Diagnostic Substances). Antal børser, hvor selskabets aktier handles: 1. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om Virksomheden

Websted
greenlandmines.com
Investorrelationer
ir.greenlandmines.com/
Sektor
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Hovedkontor
OMAHA, United States
Administrerende Direktør
Joseph A. Sinkule Pharm.D.
Ansatte
5
Udestående Aktier
158.85 mio. pr. 2026-08-17
Free Float
2.62 mio.
Markedsværdi
80.88 mio. USD
Insidere
3.81%
Institutionelle Investorer
6.34%
Branche (SIC)
Biological Products, (No Diagnostic Substances)
P/E
underskud
FCF
−14.2 mio. USD
Gæld
870 t. USD
Indtjening og FCF — for de 12 måneder frem til 30.06.2026 (virksomhedens seneste rapport).
NAV
0.36 USD · P/NAV 17.8
Balance sheet date30.06.2026
Assets65.0 mio. USD
− Liabilities7.11 mio. USD
= NAV (aktiekapital i selskabets aktionærer)57.9 mio. USD
− Intangible assets48.7 mio. USD
= Tangible NAV9.23 mio. USD
Aktier158 850 637
NAV per share0.36 USD
Håndgribelig NAV pr. Aktie0.06 USD
Share price (GRML)6.4900 USD
P/NAV17.80
NAV history
Balance sheet dateNAVNAV per share
30.06.202657.9 mio. USD0.36 USD
31.03.202651.5 mio. USD0.42 USD
31.12.20259.46 mio. USD0.13 USD
30.09.20259.93 mio. USD0.14 USD
30.06.202510.7 mio. USD0.20 USD
31.03.2025639 t. USD0.02 USD
31.12.20241.19 mio. USD0.04 USD
30.09.20241.46 mio. USD0.07 USD
Beskrivelse

Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.

annonce

Børser og Tickere

BørsTickerValutaPrisType
US USA StocksGRMLUSD6.49 +17.15%almindelige aktier

Kurs over 3 Måneder

US:GRML · USD
stigningsdag faldsdagHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Største Ejere

EjerAndelAktierRapportdato
SINKULE JOSEPH (Chief Ex…≈72.04%6.35 mio.2026-03-04
LEBLANC JEFF (Chief Fina…≈54.72%4.82 mio.2026-07-16
ZENTMAN SAMUEL M (Direct…≈12.33%1.09 mio.2026-03-04
HIRSCHMAN SHALOM Z (Dire…≈10.32%908 8732026-03-04
MCGARITY JON W (Director…≈6.26%551 2772026-07-20
SAWYER JASON DAVID (Dire…≈2.72%240 0002026-07-22
EL-DADA RIAD HUSSEIN (Di…≈1.99%175 0002026-06-25
Meteora Capital, LLC1.22%107 4752026-06-30
Citadel Advisors Llc1.17%103 3132026-06-30
Vanguard Capital Managem…0.69%60 7672026-06-30
VANGUARD INDEX FUNDS-Van…0.35%30 9562026-06-30
VANGUARD INDEX FUNDS-Van…0.34%29 8112026-06-30
Geode Capital Management…0.23%20 5452026-06-30
Davidson Kempner Capital…0.23%20 0002026-06-30
Vanguard Fiduciary Trust…0.15%12 8342026-06-30
Fidelity Concord Street…0.13%11 4442026-07-31
Renaissance Technologies…0.1%9 1422026-06-30
State Street Corporation0.07%6 0502026-06-30
UBS Group AG0.06%5 2852026-06-30
Northern Trust Corporati…0.06%4 9482026-06-30
Fidelity Concord Street…0.04%3 1842026-07-31
Fidelity Concord Street…0.03%3 0742026-07-31
Fidelity Concord Street…0%3502026-07-31
John Hancock Variable In…0%482026-06-30